The FDA announced on November 30, 2012, that West-Ward Pharmaceutical Corp. is recalling Carisoprodol Tablets, USP, 350 mg because the labeling lacked the required "C-IV" imprint for a controlled substance. The agency stated the recall addresses a failure to relabel products distributed after the June 11, 2012 deadline.
How to tell if you have it
- Brand: West-Ward Pharmaceutical
- Product: Carisoprodol Tablets 350 mg
- NDC: 0143-1176-01
- Lot #: 69160A
- Quantity: 1763 bottles
The hazard
The product is a schedule IV (C-IV) controlled substance that was distributed without the required "C-IV" imprint on the label. This omission occurred because the product was not relabeled in compliance with a DEA final rule published on December 12, 2011.
Context
GovInfoNow's records show West-Ward Pharmaceutical Corp. has 23 other recalls on record since April 13, 2012. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026) and Wells Pharma Fentanyl Citrate Solution Recall (April 1, 2026).